<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcpediatr&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Pediatrics - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcpediatr/</link>
        <description>The latest research articles published by BMC Pediatrics</description>
        <dc:date>2009-11-24T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/72" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/71" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/70" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/69" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/68" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/67" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/66" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/65" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/64" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2431/9/63" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/72">
        <title>Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis</title>
        <description>Background:
About 10-20% of neonates with suspected or proven early onset sepsis (EOS) fail on the empiric antibiotic regimen of ampicillin or penicillin and gentamicin.AimWe aimed to identify clinical and laboratory markers associated with empiric antibiotic treatment failure in neonates with suspected EOS.
Methods:
Maternal and early neonatal characteristics predicting failure of empiric antibiotic treatment were identified by univariate logistic regression analysis from a prospective database of 283 neonates admitted to neonatal intensive care unit within 72 hours of life and requiring antibiotic therapy with penicillin or ampicillin and gentamicin. Variables, identified as significant by univariate logistic regression analysis, were entered into stepwise multiple logistic regression (MLR) analysis and classification and regression tree (CRT) analysis to develop a decision algorithm for clinical application. In order to ensure the earliest possible timing separate analysis for 24 and 72 hours of age was performed.
Results:
At 24 hours of age neonates with hypoglycaemia &lt;=2.55 mmol/L together with CRP values &gt;1.35 mg/L or those with BW &lt;=678 g had more than 30% likelihood of treatment failure. In normoglycaemic neonates with higher BW the best predictors of treatment failure at 24 hours were GA &lt;= 27 weeks and among those, with higher GA, WBC &lt;= 8.25 x 109 L-1 together with platelet count &lt;= 143 x 109 L-1. The algorithm allowed capture of 75% of treatment failure cases with a specificity of 89%. By 72 hours of age minimum platelet count &lt;=94.5 x 109 L-1 with need for vasoactive treatment or leukopaenia &lt;= 3.5 x 109 L-1 or leukocytosis &gt; 39.8 x 109 L-1 or blood glucose &lt;= 1.65 mmol/L allowed capture of 81% of treatment failure cases with the specificity of 88%. The performance of MLR and CRT models was similar, except for higher specificity of the CRT at 72 h, compared to MLR analysis.
Conclusions:
There is an identifiable group of neonates with high risk of EOS, likely to fail on conventional antibiotic therapy.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/72</link>
                <dc:creator>Tuuli Metsvaht</dc:creator>
                <dc:creator>Heti Pisarev</dc:creator>
                <dc:creator>Mari-Liis Ilmoja</dc:creator>
                <dc:creator>Ulle Parm</dc:creator>
                <dc:creator>Lea Maipuu</dc:creator>
                <dc:creator>Mirjam Merila</dc:creator>
                <dc:creator>Piia Muursepp</dc:creator>
                <dc:creator>Irja Lutsar</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:72</dc:source>
        <dc:date>2009-11-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-72</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>72</prism:startingPage>
        <prism:publicationDate>2009-11-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/71">
        <title>Late preterm birth is a risk factor for growth faltering in early childhood: a cohort study</title>
        <description>Background:
Rates of preterm birth are increasing worldwide and this increase is mostly due to infants born between 34 and 36 weeks of gestational age, the so-called &quot;late preterm&quot; births. The aim of this study was to assess the effect of late preterm birth over growth outcomes, assessed when children were 12 and 24 months old.
Methods:
In 2004, all births taking place in Pelotas (Southern Brazil) were recruited for a cohort study. Late preterm (34/0-36/6 weeks of gestational age) and term children (37/0-42/6 weeks) were compared in terms of weight-for-age, length-for-age and weight-for-length z-scores. Weight-for-age, length-for-age and weight-for-length z-scores below -2 were considered, respectively, underweight, stunting and wasting. Singleton newborns with adequate weight for gestational age at birth, successfully followed-up either at 12 or 24 months of age were analyzed and adjusted odds ratios with 95% confidence intervals calculated through logistic regression.
Results:
3285 births were included, 371 of whom were late preterm births (11.3%). At 12 months, prevalence of underweight, stunting and wasting were, respectively, 3.4, 8.7 and 1.1% among late preterm children, against 1.0, 3.4 and 0.3% among term children. At 24 months, correspondent values were 3.0, 7.2 and 0.8% against 0.8, 2.9 and 0.4%. Comparing with the term children, adjusted odds of being underweighted among late preterm children was 2.57 times higher (1.27; 5.23) at 12 months and 3.36 times higher (1.56; 7.23) at 24; of being stunted, 2.35 (1.49; 3.70) and 2.30 (1.40; 3.77); and of being wasted, 3.98 (1.07; 14.85) and 1.87 (0.50; 7.01). Weight gain from birth to 12 and 24 months was similar in late preterm and term children, whereas length gain was higher in the former group in both periods.
Conclusion:
Late preterm children grow faster than children born at term, but they are at increased risk of underweight and stunting in the first two years of life. Failure to thrive in the first two years may put them at increased risk of future occurrences of serious morbidity in late childhood and of chronic disease development in adult life.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/71</link>
                <dc:creator>Ina Santos</dc:creator>
                <dc:creator>Alicia Matijasevich</dc:creator>
                <dc:creator>Marlos Domingues</dc:creator>
                <dc:creator>Aluisio Barros</dc:creator>
                <dc:creator>Cesar Victora</dc:creator>
                <dc:creator>Fernando Barros</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:71</dc:source>
        <dc:date>2009-11-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-71</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>71</prism:startingPage>
        <prism:publicationDate>2009-11-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/70">
        <title>Comparison of a new transcutaneous bilirubinometer (Bilimed(R)) with serum bilirubin measurements in preterm and full-term infants</title>
        <description>Background:
The gold standard to assess hyperbilirubinemia in neonates remains the serum bilirubin measurement. Unfortunately, this is invasive, painful, and costly. Bilimed (R), a new transcutaneous bilirubinometer, suggests more accuracy compared to the existing non-invasive bilirubinometers because of its new technology. It furthermore takes into account different skin colours. No contact with the skin is needed during measurement, no additional material costs occur. Our aim was to assess the agreement between the Bilimed (R) and serum bilirubin in preterm and term infants of different skin colours.
Methods:
The transcutaneous bilirubin measurements were performed on the infant&apos;s sternum and serum bilirubin was determined simultaneously. The agreement between both methods was assessed by Pearson`s correlation and by Bland-Altman analysis.
Results:
A total of 117 measurement cycles were performed in 99 term infants (group 1), further 47 measurements in 38 preterm infants born between 34 - 36 6/7 gestational weeks (group 2), and finally 21 measurements in 13 preterm infants born between 28 - 33 6/7 gestational weeks (group 3). The mean deviation and variability (+/-2SD) of the transcutaneous from serum bilirubin were: -14 (+/-144) umol/l ;-0.82 (+/-8.4) mg/dl in group 1, +16 (+/-91) umol/l;+0.93(+/-5.3) mg/dl in group 2 and -8 (+/-76) umol/l; -0.47 (+/-4.4) mg/dl in group 3. These limits of agreement are too wide to be acceptable in a clinical setting. Moreover, there was to be a trend towards less good agreement with increasing bilirubin values.
Conclusion:
Despite its new technology the Bilimed(R) has no advantages, and more specifically no better agreement not only in term and near-term Caucasian infants, but also in non-Caucasian and more premature infants.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/70</link>
                <dc:creator>Tanja Karen</dc:creator>
                <dc:creator>Hans Ulrich Bucher</dc:creator>
                <dc:creator>Jean-Claude Fauchere</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:70</dc:source>
        <dc:date>2009-11-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-70</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>70</prism:startingPage>
        <prism:publicationDate>2009-11-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/69">
        <title>&quot;Why do paediatricians prescribe antibiotics? Results of an Italian regional project&quot;</title>
        <description>Background:
To investigate determinants of antibiotic prescription in paediatric care, as a first step of a multilevel intervention to improve prescribing for common respiratory tract infections (RTIs) in a northern Italian region with high antibiotic prescription rate.
Methods:
A two-step survey was performed: in phase I, knowledge, and attitudes were explored involving all family and hospital paediatricians of Emilia-Romagna and a sample of parents. In phase II, patient care practices were explored in a stratified random sample of visits, both in hospitals and family physician&apos;s clinics; parent expectations were investigated in a sub-sample of these visits.
Results:
Out of overall 4352 visits for suspected RTIs, in 38% of children an antibiotic was prescribed. Diagnostic uncertainty was perceived by paediatricians as the most frequent cause of inappropriate prescription (56% of 633 interviewed paediatricians); but, rapid antigen detecting tests was used in case of pharyngitis/pharyngotonsillitis by 36% and 21% of family and hospital paediatricians only. More than 50% of paediatricians affirmed to not adopt a &quot;wait and see strategy&quot; in acute otitis. The perceived parental expectation of antibiotics was not indicated by paediatricians as a crucial determinant of prescription, but this perception was the second factor most strongly associated to prescription (OR = 12.8; 95% CI 10.4 - 15.8), the first being the presence of othorrea. Regarding parents, the most important identified factors, potentially associated to overprescribing, were the lack of knowledge of RTIs and antibiotics (41% of 1029 parents indicated bacteria as a possible cause of common cold), and the propensity to seek medical care for trivial infections (48% of 4352 children accessing ambulatory practice presented only symptoms of common cold).
Conclusion:
A wide gap between perceived and real determinants of antibiotic prescription exists. This can promote antibiotic overuse. Inadequate parental knowledge can also induce inappropriate prescription. The value of this study is that it simultaneously explored determinants of antimicrobial prescribing in an entire region involving both professionals and parents.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/69</link>
                <dc:creator>Maria Luisa Moro</dc:creator>
                <dc:creator>Massimiliano Marchi</dc:creator>
                <dc:creator>Carlo Gagliotti</dc:creator>
                <dc:creator>Simona Di Mario</dc:creator>
                <dc:creator>Davide Resi</dc:creator>
                <dc:creator>Progetto Bambini e Antibiotici Regional Group [ProBA] Group</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:69</dc:source>
        <dc:date>2009-11-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-69</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>69</prism:startingPage>
        <prism:publicationDate>2009-11-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/68">
        <title>Health related quality of life of Dutch children: psychometric properties of the PedsQL in the Netherlands </title>
        <description>Background:
Knowledge about psychometric properties of the Pediatric Quality of Life Inventory (PedsQL) in the Netherlands is limited and Dutch reference data are lacking. Aim of the current study is to collect Dutch reference data of the PedsQL and subsequently assess reliability, socio-demographic within-group differences and construct validity.
Methods:
In this study the PedsQL was administered to Dutch children aged 5 to 18 years. A socio-demographic questionnaire was completed as well. The sample consisted of three age groups: 5-7 years (parent proxy report), 8-12 years and 13-18 years (child self report). Analysis was performed with SPSS 16.0.2. A reliability analysis was done using Cronbach&apos;s alpha coefficient. Socio-demographic within-group differences were assessed by means of an ANOVA with post hoc Bonferroni correction and t-tests. Subsequently, construct validity was determined by t-tests and effect sizes.
Results:
For 496 children PedsQL reference data were collected. PedsQL total scores were 84.18 (group 5-7), 82.11 (group 8-12) and 82.24 (group 13-18). Internal consistency coefficients ranged from .53 to .85. Socio-demographic within-group differences demonstrated that, in group 8-12, children of parents born in the Netherlands had significantly lower scores on several PedsQL subscales, compared to children of parents born in another country. With respect to construct validity, healthy children of group 5-7 and 13-18 scored significantly higher than children with a chronic health condition on all subscales, except for emotional functioning. In group 5-7, the PedsQL total score for healthy children was 85.31, whereas the same age group with a chronic health condition scored 78.80. Effect sizes in this group varied from 0.58 to 0.88. With respect to group 13-18, healthy children obtained a PedsQL total score of 83.14 and children suffering from a chronic health condition 77.09. Effect sizes in this group varied from 0.45 to 0.67. No significant differences were found in group 8-12 regarding health.
Conclusion:
The Dutch version of the PedsQL has adequate psychometric properties and can be used as a health related quality of life instrument in paediatric research in the Netherlands.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/68</link>
                <dc:creator>Vivian Engelen</dc:creator>
                <dc:creator>Marleen Haentjens</dc:creator>
                <dc:creator>Symone Detmar</dc:creator>
                <dc:creator>Hendrik Koopman</dc:creator>
                <dc:creator>Martha Grootenhuis</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:68</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-68</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>68</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/67">
        <title>Impact of 4.0% chlorhexidine cleansing of the umbilical cord on mortality and omphalitis among newborns of Sylhet, Bangladesh: design of a community-based cluster randomized trial</title>
        <description>Background:
The World Health Organization recommends dry cord care for newborns but this recommendation may not be optimal in low resource settings where most births take place in an unclean environment and infections account for up to half of neonatal deaths. A previous trial in Nepal indicated that umbilical cord cleansing with 4.0% chlorhexidine could substantially reduce mortality and omphalitis risk, but policy changes await additional community-based data.
Methods:
The Projahnmo Chlorhexidine study was a three-year, cluster-randomized, community-based trial to assess the impact of three cord care regimens on neonatal mortality and omphalitis. Women were recruited mid-pregnancy, received a basic package of maternal and neonatal health promotion messages, and were followed to pregnancy outcome. Newborns were visited at home by local village-based workers whose areas were randomized to either 1) single- or 2) 7-day cord cleansing with 4.0% chlorhexidine, or 3) promotion of dry cord care as recommended by WHO. All mothers received basic messages regarding hand-washing, clean cord cutting, and avoidance of harmful home-base applications to the cord. Death within 28 days and omphalitis were the primary outcomes; these were monitored directly through home visits by community health workers on days 1, 3, 6, 9, 15, and 28 after birth.DiscussionDue to report in early 2010, the Projahnmo Chlorhexidine Study examines the impact of multiple or single chlorhexidine cleansing of the cord on neonatal mortality and omphalitis among newborns of rural Sylhet District, Bangladesh. The results of this trial will be interpreted in conjunction with a similarly designed trial previously conducted in Nepal, and will have implications for policy guidelines for optimal cord care of newborns in low resource settings in Asia.Trial RegistrationClinicalTrials.gov (NCT00434408)</description>
        <link>http://www.biomedcentral.com/1471-2431/9/67</link>
                <dc:creator>Luke Mullany</dc:creator>
                <dc:creator>Shams El Arifeen</dc:creator>
                <dc:creator>Peter Winch</dc:creator>
                <dc:creator>Rasheduzzaman Shah</dc:creator>
                <dc:creator>Ishtiaq Mannan</dc:creator>
                <dc:creator>Syed Rahman</dc:creator>
                <dc:creator>Mohammad Rahman</dc:creator>
                <dc:creator>Gary Darmstadt</dc:creator>
                <dc:creator>Saifuddin Ahmed</dc:creator>
                <dc:creator>Mathuram Santosham</dc:creator>
                <dc:creator>Robert Black</dc:creator>
                <dc:creator>Abdullah Baqui</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:67</dc:source>
        <dc:date>2009-10-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-67</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>67</prism:startingPage>
        <prism:publicationDate>2009-10-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/66">
        <title>The relationship of bottle feeding and other sucking behaviors with speech disorder in Patagonian preschoolers</title>
        <description>Background:
Previous studies have shown that children&apos;s nonnutritive sucking habits may lead to delayed development of their oral anatomy and functioning. However, these findings were inconsistent. We investigated associations between use of bottles, pacifiers, and other sucking behaviors with speech disorders in children attending three preschools in Punta Arenas (Patagonia), Chile.
Methods:
Information on infant feeding and sucking behaviors, age starting and stopping breast- and bottle-feeding, pacifier use, and other sucking behaviors, was collected from self-administered questionnaires completed by parents. Evaluation of speech problems was conducted at preschools with subsequent scoring by a licensed speech pathologist using age-normative standards.
Results:
A total of 128 three- to five-year olds were assessed, 46% girls and 54% boys. Children were breastfed for an average of 25.2 (SD 9.6) months and used a bottle 24.4 (SD 15.2) months. Fifty-three children (41.7%) had or currently used a pacifier for an average of 11.4 (SD 17.3) months; 23 children (18.3%) were reported to have sucked their fingers. Delayed use of a bottle until after 9 months appeared to be protective for subsequent speech disorders. There was less than a one-third lower relative odds of subsequent speech disorders for children with a delayed use of a bottle compared to children without a delayed use of a bottle (OR: 0.32, 95% CI: 0.10-0.98). A three-fold increase in relative odds of speech disorder was found for finger-sucking behavior (OR: 2.99, 95% CI: 1.10-8.00) and for use of a pacifier for 3 or more years (OR: 3.42, 95% CI: 1.08-10.81).
Conclusion:
The results suggest extended use of sucking outside of breastfeeding may have detrimental effects on speech development in young children.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/66</link>
                <dc:creator>Clarita Barbosa</dc:creator>
                <dc:creator>Sandra Vasquez</dc:creator>
                <dc:creator>Mary Parada</dc:creator>
                <dc:creator>Juan Carlos Velez Gonzalez</dc:creator>
                <dc:creator>Chanaye Jackson</dc:creator>
                <dc:creator>N. David Yanez</dc:creator>
                <dc:creator>Bizu Gelaye</dc:creator>
                <dc:creator>Annette Fitzpatrick</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:66</dc:source>
        <dc:date>2009-10-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-66</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>66</prism:startingPage>
        <prism:publicationDate>2009-10-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/65">
        <title>Evaluation of seasonal patterns of Kawasaki Syndrome- and rotavirus-associated Hospitalizations in California and New York, 2000-2005</title>
        <description>Background:
Kawasaki Syndrome (KS) is an uncommon childhood disease with unknown etiology. It has been suggested that rotavirus infection may play a causative role in the development of KS.
Methods:
To examine potential temporal associations between KS and rotavirus infection, seasonal patterns of KS- and rotavirus-associated hospitalizations among children in California and New York during 2000-2005 were compared.
Results:
Rotavirus hospital admissions were markedly winter seasonal, with very few summer hospitalizations. KS hospitalizations occurred year-round but also peaked slightly during winter and spring.
Conclusion:
The strong winter seasonal pattern of rotavirus clearly differed from the year-round pattern of KS hospitalizations. While the present study cannot completely rule out rotavirus as having a role in the development of KS, other agents must be involved in the etiology of KS.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/65</link>
                <dc:creator>Adam MacNeil</dc:creator>
                <dc:creator>Robert Holman</dc:creator>
                <dc:creator>Krista Yorita</dc:creator>
                <dc:creator>Claudia Steiner</dc:creator>
                <dc:creator>Umesh Parashar</dc:creator>
                <dc:creator>Ermias Belay</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:65</dc:source>
        <dc:date>2009-10-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-65</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>65</prism:startingPage>
        <prism:publicationDate>2009-10-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/64">
        <title>Prevalence and risk factors for stunting and severe stunting among under-fives in North Maluku province of Indonesia </title>
        <description>Background:
Adequate nutrition is needed to ensure optimum growth and development of infants and young children. Understanding of the risk factors for stunting and severe stunting among children aged less than five years in North Maluku province is important to guide Indonesian government public health planners to develop nutrition programs and interventions in a post conflict area. The purpose of the current study was to assess the prevalence of and the risk factors associated with stunting and severe stunting among children aged less than five years in North Maluku province of Indonesia.
Methods:
The health and nutritional status of children aged less than five years was assessed in North Maluku province of Indonesia in 2004 using a cross-sectional multi-stage survey conducted on 750 households from each of the four island groups in North Maluku province. A total of 2168 children aged 0-59 months were used in the analysis.
Results:
Prevalence of stunting and severe stunting were 29% (95%CI: 26.0-32.2) and 14.1% (95%CI: 11.7-17.0) for children aged 0-23 months and 38.4% (95%CI: 35.9-41.0) and 18.4% (95%CI: 16.1-20.9) for children aged 0-59 months, respectively. After controlling for potential confounders, multivariate analysis revealed that the risk factors for stunted children were child&apos;s age in months, male sex and number of family meals per day (&#8804;2 times), for children aged 0-23 months, and income (poorest and middle-class family), child&apos;s age in months and male sex for children aged 0-59 months. The risk factors for severe stunting in children aged 0-23 months were income (poorest family), male sex and child&apos;s age in months and for children aged 0-59 months were income (poorest family), father&apos;s occupation (not working), male sex and child&apos;s age in months.
Conclusion:
Programmes aimed at improving stunting in North Maluku province of Indonesia should focus on children under two years of age, of male sex and from families of low socioeconomic status.</description>
        <link>http://www.biomedcentral.com/1471-2431/9/64</link>
                <dc:creator>Ramli .</dc:creator>
                <dc:creator>Kingsley Agho</dc:creator>
                <dc:creator>Kerry Inder</dc:creator>
                <dc:creator>Steven Bowe</dc:creator>
                <dc:creator>Jennifer Jacobs</dc:creator>
                <dc:creator>Michael Dibley</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:64</dc:source>
        <dc:date>2009-10-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-64</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>64</prism:startingPage>
        <prism:publicationDate>2009-10-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2431/9/63">
        <title>ADEPT - Abnormal Doppler Enteral Prescription Trial</title>
        <description>Background:
Pregnancies complicated by abnormal umbilical artery Doppler blood flow patterns often result in the baby being born both preterm and growth-restricted. These babies are at high risk of milk intolerance and necrotising enterocolitis, as well as post-natal growth failure, and there is no clinical consensus about how best to feed them. Policies of both early milk feeding and late milk feeding are widely used. This randomised controlled trial aims to determine whether a policy of early initiation of milk feeds is beneficial compared with late initiation. Optimising neonatal feeding for this group of babies may have long-term health implications and if either of these policies is shown to be beneficial it can be immediately adopted into clinical practice.Methods and DesignBabies with gestational age below 35 weeks, and with birth weight below 10th centile for gestational age, will be randomly allocated to an &quot;early&quot; or &quot;late&quot; enteral feeding regimen, commencing milk feeds on day 2 and day 6 after birth, respectively. Feeds will be gradually increased over 9-13 days (depending on gestational age) using a schedule derived from those used in hospitals in the Eastern and South Western Regions of England, based on surveys of feeding practice. Primary outcome measures are time to establish full enteral feeding and necrotising enterocolitis; secondary outcomes include sepsis and growth. The target sample size is 400 babies. This sample size is large enough to detect a clinically meaningful difference of 3 days in time to establish full enteral feeds between the two feeding policies, with 90% power and a 5% 2-sided significance level. Initial recruitment period was 24 months, subsequently extended to 38 months.DiscussionThere is limited evidence from randomised controlled trials on which to base decisions regarding feeding policy in high risk preterm infants. This multicentre trial will help to guide clinical practice and may also provide pointers for future research.Trial registrationCurrent Controlled Trials ISRCTN: 87351483</description>
        <link>http://www.biomedcentral.com/1471-2431/9/63</link>
                <dc:creator>Alison Leaf</dc:creator>
                <dc:creator>Jon Dorling</dc:creator>
                <dc:creator>Steve Kempley</dc:creator>
                <dc:creator>Kenny McCormick</dc:creator>
                <dc:creator>Paul Mannix</dc:creator>
                <dc:creator>Peter Brocklehurst</dc:creator>
                <dc:source>BMC Pediatrics 2009, 9:63</dc:source>
        <dc:date>2009-10-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2431-9-63</dc:identifier>
        <prism:publicationName>BMC Pediatrics</prism:publicationName>
        <prism:issn>1471-2431</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>63</prism:startingPage>
        <prism:publicationDate>2009-10-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
